Evidence map›Paper›PMID 39028385›Full record

ArticleAIDS and behavior2024

Enhanced Oral Pre-exposure Prophylaxis (PrEP) Implementation for Ugandan Fisherfolk: Pilot Intervention Outcomes.

Laura M Bogart, William Musoke, Christopher Semei Mukama, Stella Allupo, David J Klein, Abdulrazake Sejjemba, Simon Mwima, Herbert Kadama, Ronald Mulebeke, Rakesh Pandey and 3 more

2 registry-linked trialsAbstract read
In one paragraph

Article in AIDS and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05084716 nacompletednot on this map

PrEP Provision for Ugandan Fisherfolk

TypeinterventionalSponsorRANDRan2021 to 2023Enrolled885ConditionsHIVArmsEnhanced PrEP provision
NCT07382765 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

In This toGether: Testing a Population-based Text Messaging-based HIV Prevention Program for Young Adults Across Uganda

TypeinterventionalSponsorCenter for Innovative Public Health ResearchRan2026 to 2028Enrolled750ConditionsHIVArmsLevel up quizzes, Badges, On-demand advice, Content
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laura M BogartRAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA. lbogart@rand.org.ORCID http://orcid.org/0000-0003-3182-5542
William MusokeMildmay Uganda, Kampala, Uganda.
Christopher Semei MukamaMildmay Uganda, Kampala, Uganda.
Stella AllupoMildmay Uganda, Kampala, Uganda.
David J KleinRAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
Abdulrazake SejjembaMildmay Uganda, Kampala, Uganda.
Simon MwimaSchool of Social Work, University of Illinois at Urbana Champagne, Urbana, IL, USA.
Herbert KadamaMinistry of Health, Republic of Uganda, Kampala, Uganda.
Ronald MulebekeMildmay Uganda, Kampala, Uganda.
Rakesh PandeyRAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
Zachary WagnerRAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
Barbara Mukasa *Mildmay Uganda, Kampala, Uganda.
Rhoda K Wanyenze *Makerere University School of Public Health, Kampala, Uganda.

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Evaluation of the Implementation of PrEP Provision for Ugandan FisherfolkR34MH119924 · NIMH · RAND CORPORATION · PI BOGART, LAURA M, WANYENZE, RHODA KITTI · 2020 to 2022
$643k
NIMH NIH HHS P30 MH058107NIMH NIH HHS P30MH058107NIMH NIH HHS R34 MH119924
6 · The paper itself

Abstract

Mobile populations such as fisherfolk show high HIV incidence and prevalence. We pilot-tested implementation strategies to enhance pre-exposure prophylaxis (PrEP) uptake and adherence in the context of healthcare outreach events in two mainland fisherfolk communities on Lake Victoria, Uganda from September 2021 to February 2022. The implementation strategies included PrEP adherence supporters (selected from PrEP users' social networks), community workshops (to address misconceptions and stigma, and empower PrEP advocacy), and check-in calls (including refill reminders). PrEP medical records data were collected from 6-months pre-intervention to 6-months post-intervention. Qualitative interviews with 20 PrEP users (10 who continued, 10 who discontinued), 9 adherence supporters, and 7 key partners (providers, community leaders) explored acceptability. Percentages of PrEP initiators (of those eligible) were significantly higher during the intervention (96.5%) than 6-months before the intervention (84.5%), p < 0.0001; percentages of PrEP users who persisted (i.e., possessed a refill) 6-months post-initiation (47.9% vs. 6.7%) and had at least 80% PrEP coverage (based on their medication possession ratio) from the initiation date to 6-months later (35.9% vs. 0%) were higher during versus pre-intervention, p < 0.0001. A comparison fisherfolk community with better healthcare access had lower uptake (78.3%; p < 0.0001) and persistence at 6-months (34.0%; p < 0.001), but higher coverage during the intervention period (70.4%; p < 0.0001). Qualitative data suggested the strategies promoted PrEP use through reduced stigma and misconceptions. The intervention bundle cost was $223.95, $172.98, and $94.66 for each additional person for PrEP initiation, persistence, and coverage, respectively. Enhanced community-based PrEP implementation that fosters a supportive community environment can improve PrEP use in mobile populations without easy access to healthcare. (NCT05084716).

Indexed as

Anti-HIV AgentsDrug MonitoringHIV InfectionsPre-Exposure ProphylaxisAdministration, OralAdultFemaleHumansMaleMiddle AgedPatient Acceptance of Health CarePilot ProjectsQualitative ResearchSocial StigmaUgandaAnti-HIV AgentsFisherfolkHIVImplementation sciencePre-exposure prophylaxis (PrEP)Uganda

Identifiers

PMID39028385
PMCPMC11427177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.